Drugs / AGN-Cogni.Q
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05375539 | May 2023 → Feb 2025 | prostate cancer | Milton S. Hershey Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGN-Cogni.Q | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05375539 ↗ |
| Known as | Cogni.QTM | “AGN-Cogni.Q, or Cogni.QTM, made with INM®176 proprietary ingredient” NCT05375539 ↗ |